Inventys intends to add – over three phases – a new reaction capacity of 300+ batch and flow reactors. A total new reaction capacity of more than 2,000,000 liters is expected to be added needing an investment in excess of INR 1,200 crores. Phase 1 of the expansion is supported by the private equity infusion led by Plutus Wealth Management LLP and India Inflection Opportunity Fund, managed by Pantomath Capital Management Pvt. Ltd.
Deepak Birewar, Chairman & MD, Inventys Research, said in a statement, “Our USP lies in our ability to develop highly complex chemicals across various life science segments. We are now aiming to rapidly scale further with capital, regulatory permissions, process technology, product pipeline, and customer demand already secured. Phase 1 of the expansion is expected to be completed in FY2024.”
Growing a product from the laboratory stage to 100+MT-level production is one of the company’s significant strengths.
Inventys adheres to the principles of circularity. Having converted more than 66% of its energy usage from non-depletable resources and more than 25% of its revenue from non-effluent-generating processes – the company was recently awarded the ‘Best Green Process award’ (2022) in the sustainable category at FICCI Chemicals and Petrochemicals Award 2022 for developing chemical process involving Zero Effluent Generation Technology.
Incorporated in 2005, Inventys is headquartered in Mumbai with its manufacturing facilities in Nagpur. Dr. Deepak Birewar, Chairman & MD established Inventys with a vision to leverage advanced technologies and ensure innovative, cost-effective, and safe manufacturing of specialty chemicals.
